LanZhou Foci Pharmaceutical Co.,Ltd.
002644.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.28B
Close$
$4.62
42.1% downside
Current Fair Value
42.1% downsideOvervalued by 42.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.28 Billion |
|---|---|
| Enterprise Value | $3.78 Billion |
| Dividend Yield | $0.02 (0.24%) |
| Earnings per Share | $0.1 |
| Beta | 0.26 |
| Outstanding Shares | 510,657,000 |
Return
| Return on Equity | 3.16% |
|---|---|
| Return on Assets | 2.25% |
| Return on Invested Capital | 3.12% |
Valuation & Multiples
| P/E Ratio | 72.83 |
|---|---|
| PEG | 122.9 |
| Price to Sales | 7.98 |
| Price to Book Ratio | 2.66 |
| Enterprise Value to Revenue | 4.08 |
| Enterprise Value to EBIT | 56.99 |
| Enterprise Value to Net Income | 64 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About LanZhou Foci Pharmaceutical Co.,Ltd.
1,332 employees
CEO: Jinfeng Yue LanZhou Foci Pharmaceutical Co.,Ltd. is a prominent pharmaceutical entity based in China, primarily focused on the manufacturing and distribution of traditional Chinese medicines. Its diverse product line, offered under the "Min Shan" an...